IGSF9B and Anxiety: Moreover, it is tempting to speculate that in the age of circuit psychiatry26, targeting IgSF9b-expressing neurons with viral vectors will become feasible, offering entirely new treatment options for patients with anxiety and co-morbid psychiatric disorders.